1. Home
  2. TNL vs ALKS Comparison

TNL vs ALKS Comparison

Compare TNL & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travel   Leisure Co.

TNL

Travel Leisure Co.

HOLD

Current Price

$62.96

Market Cap

4.7B

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$34.21

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNL
ALKS
Founded
1990
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.5B
IPO Year
2006
2012

Fundamental Metrics

Financial Performance
Metric
TNL
ALKS
Price
$62.96
$34.21
Analyst Decision
Buy
Buy
Analyst Count
7
14
Target Price
$84.00
$43.43
AVG Volume (30 Days)
825.6K
2.3M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
3.71%
N/A
EPS Growth
N/A
N/A
EPS
1.22
1.43
Revenue
$4,021,000,000.00
$1,475,899,000.00
Revenue This Year
$3.56
$24.26
Revenue Next Year
$3.55
$4.47
P/E Ratio
$52.95
$23.96
Revenue Growth
4.06
N/A
52 Week Low
$43.81
$25.17
52 Week High
$81.00
$36.48

Technical Indicators

Market Signals
Indicator
TNL
ALKS
Relative Strength Index (RSI) 32.61 58.14
Support Level $57.94 $27.48
Resistance Level $63.46 $35.25
Average True Range (ATR) 2.87 0.94
MACD -1.45 -0.11
Stochastic Oscillator 2.49 55.50

Price Performance

Historical Comparison
TNL
ALKS

About TNL Travel Leisure Co.

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including two vacation exchange brands, Vacation Ownership and Travel and Membership The majority of the revenue is earned from the United States.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: